1365155-06-1

Upstream product

• 134409-06-6 4,4-ethylenedioxy-2,2-dimethylcyclohexanone 
• 2393-23-9 4-methoxy-benzylamine 

Downstream Products

• 1365155-12-9 benzyl 7,7-dimethyl-1,4-dioxaspiro[4.5]decan-8-ylcarbamate 
• 1365155-15-2 benzyl(2,2-dimethyl-4-oxocyclohexyl)carbamate 
• 1365153-36-1 2,2-Dimethyl-4-(4-methylpiperazin-1-yl)cyclohexanamine 
• 1365155-18-5 Benzyl 2,2-dimethyl-4-(4-methylpiperazin-1-yl)cyclohexylcarbamate 

Relevant academic research and scientific papers

HYDANTOIN DERIVATIVE

A compound represented by general formula (I-a) : has a strong DDR1 inhibitory activity, and can be a therapeutic agent for DDR1-related diseases, for example, a cancer, a kidney disease, a cardiovascular disease, a central nervous system disease, or fibrosis.

Substituted Benzamide Compounds

Substituted benzamide compounds corresponding to formula (I) in which R5, R6, R7, R8, a, b, c, d, t, D and X have defined meanings, a process for their preparation, pharmaceutical compositions comprising such compounds, and a method of using such compounds to treat pain and other conditions mediated at least in part via the bradykinin 1 receptor.